Skip Navigation
Skip to contents

Cancer Res Treat : Cancer Research and Treatment

OPEN ACCESS

Search

Page Path
HOME > Search
3 "In-Hwan Oh"
Filter
Filter
Article category
Keywords
Publication year
Authors
Funded articles
Original Articles
Palliative medicine
A National Study of Life-Sustaining Treatments in South Korea: What Factors Affect Decision-Making?
So-Youn Park, Bomyee Lee, Jeong Yeon Seon, In-Hwan Oh
Cancer Res Treat. 2021;53(2):593-600.   Published online November 21, 2020
DOI: https://doi.org/10.4143/crt.2020.803
AbstractAbstract PDFSupplementary MaterialPubReaderePub
Purpose
This cross-sectional study investigated the status of life-sustaining treatment (LST) practices and identified characteristics and factors influencing decision-making practices.
Materials and Methods
The National Agency for Management of Life-sustaining Treatment retains records provided by doctors regarding patients subject to LST implementation. A total of 71,327 patients receiving LST were identified. We analyzed all nationally reported data between February 2018 and October 2019. Indicators such as the proportion of deaths, records for decision to terminate LST, implementation of LST records, and registration of Advance Statements on LST were analyzed.
Results
A total of 67,252 (94.3%) end-of life decisions were implemented in South Korea. The proportion of deaths preceded by a LST plan, non-self-determination LST decision, and any advance statements was 33.5% (23,891/71,327), 66.5% (47,436/71,327), and 1.2% (890/71,327), respectively. The logistic regression model revealed that self-determination to terminate LST was more frequent for men than for women and higher for those aged 30-69. Disability (odds ratio [OR], 0.59; 95% confidence interval [CI], 0.56 to 0.61), living in non-metropolitan areas (OR, 0.84; 95% CI, 0.81 to 0.86), and disease comorbidity was independently associated with a low level of self-determination.
Conclusion
After the implementation of the new LST Act, about a third of patients in end-of-life process made decisions regarding their medical LST. However, family members still play a major role in LST decisions where the patient’s intention cannot be verified. Decisions related to LST are predominantly made when death is imminent. Thus, it is necessary to increase awareness of end-of-life LST decision-making among medical staff and the public.

Citations

Citations to this article as recorded by  
  • Characteristics of Life-Sustaining Treatment Decisions: National Data Analysis in South Korea
    Jiyeon Choi, Heejung Jeon, Ilhak Lee
    Asian Bioethics Review.2024; 16(1): 33.     CrossRef
  • Recent Trends in the Withdrawal of Life-Sustaining Treatment in Patients with Acute Cerebrovascular Disease : 2017–2021
    Seung Hwan Kim, Ji Hwan Jang, Young Zoon Kim, Kyu Hong Kim, Taek Min Nam
    Journal of Korean Neurosurgical Society.2024; 67(1): 73.     CrossRef
  • The Impact of Withdrawing or Withholding of Life-Sustaining Treatment: A Nationwide Case-Control Study Based on Medical Cost Analysis
    Claire Junga Kim, Do-Kyong Kim, Sookyeong Mun, Minkook Son
    Journal of Korean Medical Science.2024;[Epub]     CrossRef
  • Characteristics and outcomes of patients with do-not-resuscitate and physician orders for life-sustaining treatment in a medical intensive care unit: a retrospective cohort study
    Song-I Lee, Ye-Rin Ju, Da Hyun Kang, Jeong Eun Lee
    BMC Palliative Care.2024;[Epub]     CrossRef
  • Clinical Characteristics and Prognosis of Older Patients with Coronavirus Disease 2019 Requiring Mechanical Ventilation
    Green Hong, Da Hyun Kang, Sunghoon Park, Su Hwan Lee, Onyu Park, Taehwa Kim, Hye Ju Yeo, Jin Ho Jang, Woo Hyun Cho, Song I Lee
    Journal of Personalized Medicine.2024; 14(6): 657.     CrossRef
  • Comparison of factors influencing the decision to withdraw life-sustaining treatment in intensive care unit patients after implementation of the Life-Sustaining Treatment Act in Korea
    Claire Junga Kim, Kyung Sook Hong, Sooyoung Cho, Jin Park
    Acute and Critical Care.2024; 39(2): 294.     CrossRef
  • Validation of the Korean Version of the Clinical Frailty Scale-Adjusted Korean Triage and Acuity Scale for Older Patients in the Emergency Department
    Ho Sub Chung, Yunhyung Choi, Ji Yeon Lim, Keon Kim, Sung Jin Bae, Yoon Hee Choi, Dong Hoon Lee
    Medicina.2024; 60(6): 955.     CrossRef
  • Psychosocial Factors Associated With Thoughts Regarding Life-Sustaining Treatment for Oneself and Family Members
    Jeewon Lee, Shin-Gyeom Kim, Soyoung Irene Lee, HyunChul Youn
    Psychiatry Investigation.2024; 21(6): 646.     CrossRef
  • Emergency department and intensive care unit health professionals' knowledge and application of the law that applies to end-of-life decision-making for adults: A scoping review of the literature
    Jayne Hewitt, Nemat Alsaba, Katya May, Halima Sadia Noon, Cooper Rennie, Andrea P. Marshall
    Australian Critical Care.2023; 36(4): 628.     CrossRef
  • Decision and Practice of End-of-Life Care in Lung Disease Patients with Physicians Orders for Life Sustaining Treatment
    Yu Mi Oh, Yoon Na Kang, Soo Jung Han, Jeong Hye Kim
    The Korean Journal of Hospice and Palliative Care.2023; 26(1): 7.     CrossRef
  • Advance Care Planning in South Korea
    Yu Jung Kim, Sun-Hyun Kim
    Zeitschrift für Evidenz, Fortbildung und Qualität im Gesundheitswesen.2023; 180: 68.     CrossRef
  • Participation and Influencing Factors in the Decision-Making of Life-Sustaining Treatment: A Focus on Deceased Patients with Hematologic Neoplasms
    Jae Eun Jang, Jeong Moon Ryu, Min Hee Heo, Do Eun Kwon, Ji Yeon Seo, Dong Yeon Kim
    The Korean Journal of Hospice and Palliative Care.2023; 26(2): 69.     CrossRef
  • Comparison of the end-of-life decisions of patients with hospital-acquired pneumonia after the enforcement of the life-sustaining treatment decision act in Korea
    Ae-Rin Baek, Sang-Bum Hong, Soohyun Bae, Hye Kyeong Park, Changhwan Kim, Hyun-Kyung Lee, Woo Hyun Cho, Jin Hyoung Kim, Youjin Chang, Heung Bum Lee, Hyun-Il Gil, Beomsu Shin, Kwang Ha Yoo, Jae Young Moon, Jee Youn Oh, Kyung Hoon Min, Kyeongman Jeon, Moon S
    BMC Medical Ethics.2023;[Epub]     CrossRef
  • Analysis of Cancer Patient Decision-Making and Health Service Utilization after Enforcement of the Life-Sustaining Treatment Decision-Making Act in Korea
    Dalyong Kim, Shin Hye Yoo, Seyoung Seo, Hyun Jung Lee, Min Sun Kim, Sung Joon Shin, Chi-Yeon Lim, Do Yeun Kim, Dae Seog Heo, Chae-Man Lim
    Cancer Research and Treatment.2022; 54(1): 20.     CrossRef
  • Problems Related to the Act on Decisions on Life-Sustaining Treatment and Directions for Improvement
    Dae Seog Heo, Shin Hye Yoo, Bhumsuk Keam, Sang Ho Yoo, Younsuck Koh
    The Korean Journal of Hospice and Palliative Care.2022; 25(1): 1.     CrossRef
  • Derivation and performance of an end-of-life practice score aimed at interpreting worldwide treatment-limiting decisions in the critically ill
    Spyros D. Mentzelopoulos, Su Chen, Joseph L. Nates, Jacqueline M. Kruser, Christiane Hartog, Andrej Michalsen, Nikolaos Efstathiou, Gavin M. Joynt, Suzana Lobo, Alexander Avidan, Charles L. Sprung, Wesley Ely, Erwin J. O. Kompanje, Mervyn Mer, Charles Fel
    Critical Care.2022;[Epub]     CrossRef
  • Will implementation of the Life-sustaining Treatment Decisions Act reduce the incidence of cardiopulmonary resuscitation?
    In-Ae Song
    Acute and Critical Care.2022; 37(2): 256.     CrossRef
  • The cascade of care for latent tuberculosis infection in congregate settings: A national cohort analysis, Korea, 2017–2018
    Jinsoo Min, Hyung Woo Kim, Helen R. Stagg, Molebogeng X. Rangaka, Marc Lipman, Ibrahim Abubakar, Yunhee Lee, Jun-Pyo Myong, Hyunsuk Jeong, Sanghyuk Bae, Ah Young Shin, Ji Young Kang, Sung-Soon Lee, Jae Seuk Park, Hyeon Woo Yim, Ju Sang Kim
    Frontiers in Medicine.2022;[Epub]     CrossRef
  • Preparation and Practice of the Necessary Documents in Hospital for the “Act on Decision of Life-Sustaining Treatment for Patients at the End-of-Life”
    Sun Kyung Baek, Hwa Jung Kim, Jung Hye Kwon, Ha Yeon Lee, Young-Woong Won, Yu Jung Kim, Sujin Baik, Hyewon Ryu
    Cancer Research and Treatment.2021; 53(4): 926.     CrossRef
  • 6,835 View
  • 182 Download
  • 16 Web of Science
  • 19 Crossref
Close layer
Socioeconomic Burden of Cancer in Korea from 2011 to 2015
Young Ae Kim, Ye-Rin Lee, Jeongjoo Park, In-Hwan Oh, Hoseob Kim, Seok-Jun Yoon, Keeho Park
Cancer Res Treat. 2020;52(3):896-906.   Published online March 18, 2020
DOI: https://doi.org/10.4143/crt.2019.398
AbstractAbstract PDFPubReaderePub
Purpose
Though the socioeconomic burden of cancer on patients is increasing in South Korea, there is little research regarding the type of cancer that incurs the highest costs. This study analyzed the socioeconomic burden on cancer patients from 2011 to 2015 according to sex and age.
Materials and Methods
A prevalence-based approach was applied utilizing claim data of the National Health Insurance Service in Korea to estimate the socioeconomic burden of cancer on patients. Patients who received treatment for cancer from 2011 to 2015 were the study subjects. The total socioeconomic burden of their disease and treatment was divided into direct and indirect costs.
Results
There was an increase of 50.7% for 5 years, from 821,525 to 1,237,739 cancer patients. The cancer costs for men and women increased $8,268.4 million to $9,469.7 million and $3,626.5 million to $4,475.6 million, respectively. Furthermore, the 50-59-year-old age group accounted for a large portion of the total disease cost. Liver, lung, stomach, and colorectal cancers created the heaviest economic burdens on patients.
Conclusion
Overall, this study indicates new policies for cancer prevention, early detection, and postcancer treatment management are necessary to help limit the costs associatedwith cancer, especially in the elderly, and provides a foundation for establishing cancer-related health care policies, particularly by defining those cancers with heavier disease burdens.

Citations

Citations to this article as recorded by  
  • Socioeconomic Burden of Psychiatric Cancer Patients: A Narrative Review
    Gniewko Więckiewicz, Sophie Weber, Iga Florczyk, Piotr Gorczyca
    Cancers.2024; 16(6): 1108.     CrossRef
  • Comparison between Nivolumab and Regorafenib as Second-line Systemic Therapies after Sorafenib Failure in Patients with Hepatocellular Carcinoma
    Hong Jun Lee, Jae Seung Lee, Hyesung So, Ja Kyung Yoon, Jin-Young Choi, Hye Won Lee, Beom Kyung Kim, Seung Up Kim, Jun Yong Park, Sang Hoon Ahn, Do Young Kim
    Yonsei Medical Journal.2024; 65(7): 371.     CrossRef
  • Impact of early economic activity loss on all-cause mortality in gastric cancer survivors following curative treatment: a nationwide study in Korea
    Byungyoon Yun, Juyeon Oh, Heejoo Park, Jinsoo Chung, Juho Sim, Jongmin Lee, Yangwook Kim, Jin-Ha Yoon
    Gastric Cancer.2024; 27(6): 1159.     CrossRef
  • Economic Burden of Healthcare Services on Cancer Survivors in Bangladesh
    Md. Shahjalal, Padam Kanta Dahal, Md. Parvez Mosharaf, Mohammad Morshad Alam, Mohammad Delwer Hossain Hawlader, Rashidul Alam Mahumud
    Cancer Reports.2024;[Epub]     CrossRef
  • High-Dose Corticosteroid Use in Severe to Critically Ill Patients With COVID-19: A Nationwide Population-Based Matched Cohort Study
    Raeseok Lee, Sung-Yeon Cho, Dong-Gun Lee, Dukhee Nho
    Journal of Korean Medical Science.2024;[Epub]     CrossRef
  • 2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma

    Journal of Liver Cancer.2023; 23(1): 1.     CrossRef
  • Incidence of dysphagia requiring medical attention in various types of cancers: A nationwide population-based cohort study
    SuYeon Kwon, Gowun Kim, Seungwoo Cha, Kyungdo Han, Nam-Jong Paik, Won-Seok Kim
    Supportive Care in Cancer.2023;[Epub]     CrossRef
  • Economic burden of cancer attributable to modifiable risk factors in Japan
    Eiko Saito, Shiori Tanaka, Sarah Krull Abe, Mayo Hirayabashi, Junko Ishihara, Kota Katanoda, Yingsong Lin, Chisato Nagata, Norie Sawada, Ribeka Takachi, Atsushi Goto, Junko Tanaka, Kayo Ueda, Megumi Hori, Tomohiro Matsuda, Manami Inoue
    Global Health & Medicine.2023; 5(4): 238.     CrossRef
  • Operational Definitions of Colorectal Cancer in the Korean National Health Insurance Database
    Hyeree Park, Yu Rim Kim, Yerin Pyun, Hyundeok Joo, Aesun Shin
    Journal of Preventive Medicine and Public Health.2023; 56(4): 312.     CrossRef
  • The effects of hospice care on healthcare expenditure among cancer patients
    Hoyol Jhang, Wonjeong Jeong, Hyun-Soo Zhang, Dong-Woo Choi, Hyejung Kang, Sohee Park
    BMC Health Services Research.2023;[Epub]     CrossRef
  • Validation of Cancer Diagnosis Based on the National Health Insurance Service Database versus the National Cancer Registry Database in Korea
    Min Soo Yang, Minae Park, Joung Hwan Back, Gyeong Hyeon Lee, Ji Hye Shin, Kyuwoong Kim, Hwa Jeong Seo, Young Ae Kim
    Cancer Research and Treatment.2022; 54(2): 352.     CrossRef
  • Income Disparities in Cancer Screening: A Cross-Sectional Study of the Korean National Health and Nutrition Examination Survey, 2013–2019
    Vasuki Rajaguru, Tae Hyun Kim, Jaeyong Shin, Sang Gyu Lee
    Frontiers in Public Health.2022;[Epub]     CrossRef
  • The cost of oral cancer: A systematic review
    Rejane Faria Ribeiro-Rotta, Eduardo Antônio Rosa, Vanessa Milani, Nadielle Rodrigues Dias, Danielle Masterson, Everton Nunes da Silva, Ana Laura de Sene Amâncio Zara, Antoine Eskander
    PLOS ONE.2022; 17(4): e0266346.     CrossRef
  • The effect of cancer on traditional, complementary and alternative medicine utilization in Korea: a fixed effect analysis using Korea Health Panel data
    Dongsu Kim, Soo-Hyun Sung, Seungwon Shin, Minjung Park
    BMC Complementary Medicine and Therapies.2022;[Epub]     CrossRef
  • Trend Analysis and Prediction of Hepatobiliary Pancreatic Cancer Incidence and Mortality in Korea
    Hyeong Min Park, Young-Joo Won, Mee Joo Kang, Sang-Jae Park, Sun-Whe Kim, Kyu-Won Jung, Sung-Sik Han
    Journal of Korean Medical Science.2022;[Epub]     CrossRef
  • The population-level economic burden of liver cancer in China, 2019–2030: prevalence-based estimations from a societal perspective
    Meng-Di Cao, Cheng-Cheng Liu, Hong Wang, Lin Lei, Maomao Cao, Yuting Wang, He Li, Xin-Xin Yan, Yan-Jie Li, Xin Wang, Ji Peng, Chunfeng Qu, Eleonora Feletto, Ju-Fang Shi, Wanqing Chen
    Cost Effectiveness and Resource Allocation.2022;[Epub]     CrossRef
  • Real world evidence study on treatment patterns and health resource utilization in patients with HR+/HER2- locally advanced or metastatic breast cancer in Korea
    Diego Novick, Sae Young Lee, Dong Hyun Koo, Agota Szende, Sam Colman
    Journal of Drug Assessment.2022; 11(1): 12.     CrossRef
  • 2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma

    Clinical and Molecular Hepatology.2022; 28(4): 583.     CrossRef
  • 2022 KLCA-NCC Korea Practice Guidelines for the Management of Hepatocellular Carcinoma

    Korean Journal of Radiology.2022; 23(12): 1126.     CrossRef
  • Trends in breast cancer screening rates among Korean women: results from the Korean National Cancer Screening Survey, 2005-2020
    Soo Yeon Song, Yun Yeong Lee, Hye Young Shin, Bomi Park, Mina Suh, Kui Son Choi, Jae Kwan Jun
    Epidemiology and Health.2022; 44: e2022111.     CrossRef
  • Mechanisms of resistance to chemotherapy in non-small cell lung cancer
    Hye-Young Min, Ho-Young Lee
    Archives of Pharmacal Research.2021; 44(2): 146.     CrossRef
  • Analysis of Medical Use and Treatment Costs of Hepatocellular Carcinoma Patients Using National Patient Sample Data
    Byeong-Chan Oh, Jeong-Yeon Cho, Sun-Hong Kwon, Eui-Kyung Lee, Hye-Lin Kim
    Korean Journal of Clinical Pharmacy.2021; 31(2): 153.     CrossRef
  • Liver Stiffness-Based Risk Prediction Model for Hepatocellular Carcinoma in Patients with Nonalcoholic Fatty Liver Disease
    Jae Seung Lee, Dong Hyun Sinn, Soo Young Park, Hye Jung Shin, Hye Won Lee, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Joo Hyun Oh, Jung Il Lee, Seung Up Kim
    Cancers.2021; 13(18): 4567.     CrossRef
  • Economic burden of alcohol-related cancers in the Republic of Korea
    Minji Han, Binh Thang Tran, Heeyoun Cho, Jin-Kyoung Oh
    Drug and Alcohol Dependence.2020; 217: 108295.     CrossRef
  • 11,176 View
  • 257 Download
  • 25 Web of Science
  • 24 Crossref
Close layer
The Economic Burden of Breast Cancer in Korea from 2007-2010
Young Ae Kim, In-Hwan Oh, Seok-Jun Yoon, Hyun-Jin Kim, Hye-Young Seo, Eun-Jung Kim, Yo Han Lee, Jae Hun Jung
Cancer Res Treat. 2015;47(4):583-590.   Published online February 13, 2015
DOI: https://doi.org/10.4143/crt.2014.143
AbstractAbstract PDFPubReaderePub
Purpose
This study estimates the socioeconomic cost and burden for breast cancer patients in Korea between 2007 and 2010. Materials and Methods This study used a prevalence-based approach to estimate the cost of breast cancer. Breast cancer patients were defined as those who were hospitalized or have visited an outpatient clinic during the period from 2007 to 2010. The socioeconomic costs of breast cancer were subdivided into two costs: direct and indirect.
Results
From 2007 to 2010, the prevalence of treated breast cancer increased from 7.9% to 20.4%. The total socioeconomic costs incurred by breast cancer increased by approximately 40.7% from US $668.49 million in 2007 to US $940.75 million in 2010. The direct medical care costs for 2010 were 1.4 times greater (US $399.22 million) than for 2007 (US $278.71 million). The direct non-medical costs rose from US $50.69 million in 2007 to US $75.83 million in 2010, a 49.6% increase. Regarding the economic burden of breast cancer, the total indirect costs were US $339.09 million in 2007 and increased by 37.3% to US $465.70 million in 2010. In the sensitivity analysis, with the annual discount rate for each year ranging from 0%-5%, the costs increased 1.1-1.2 times. Conclusion Due to the growing incidence of breast cancer, the annual prevalence and related costs are increasing. We must strive to reduce the socioeconomic burden of breast cancer through preventive measures and early screening.

Citations

Citations to this article as recorded by  
  • Cost of illness of breast cancer in low- and middle-income countries: a systematic review
    Siew Wei Yeong, Sit Wai Lee, Siew Chin Ong
    Health Economics Review.2024;[Epub]     CrossRef
  • Therapy-related myeloid neoplasm in early breast cancer patients treated with adjuvant chemotherapy
    Ji Won Lee, Hoonji Oh, Ji Young You, Eun-Shin Lee, Jung Hyun Lee, Sung Eun Song, Nam Kwon Lee, Seung Pil Jung, Jung Seok An, Kyu Ran Cho, Cheol Yong Kim, Kyong Hwa Park
    European Journal of Cancer.2023; 191: 112952.     CrossRef
  • Economic burden of breast cancer: a case of Southern Iran
    Faride Sadat Jalali, Khosro Keshavarz, Mozhgan Seif, Majid Akrami, Abdosaleh Jafari, Ramin Ravangard
    Cost Effectiveness and Resource Allocation.2023;[Epub]     CrossRef
  • Economic burden of breast cancer in northern Serbia
    Marko Milovic, Tatjana Tamas, Veljko Crnobrnja, Milica Paut Kusturica
    Frontiers in Public Health.2023;[Epub]     CrossRef
  • Measuring Trends in the Socioeconomic Burden of Disease in Korea, 2007-2015
    Tae Eung Kim, Ru-Gyeom Lee, So-Youn Park, In-Hwan Oh
    Journal of Preventive Medicine and Public Health.2022; 55(1): 19.     CrossRef
  • The direct cost incurred by patients and caregivers in diagnosing and managing prostate cancer in Ghana
    Ebenezer Wiafe, Kofi Boamah Mensah, Kwaku Addai Arhin Appiah, Frasia Oosthuizen, Varsha Bangalee
    BMC Health Services Research.2022;[Epub]     CrossRef
  • Cost analysis of breast cancer: a comparison between private and public hospitals in Iran
    Abolhasan Afkar, Habib Jalilian, Abolghasem Pourreza, Habibeh Mir, Abdolhosein Emami Sigaroudi, Somayeh Heydari
    BMC Health Services Research.2021;[Epub]     CrossRef
  • The Economic Burden Associated with the Management of Different Stages of Breast Cancer: A Retrospective Cost of Illness Analysis in Saudi Arabia
    Ahmed Alghamdi, Bander Balkhi, Shahad Alqahtani, Hamoud Almotairi
    Healthcare.2021; 9(7): 907.     CrossRef
  • Direct Medical Costs for Stage-Specific Breast Cancer: A Retrospective Analysis
    Qais Alefan, Alaa Saadeh, Rami J Yaghan
    Breast Cancer Management.2020;[Epub]     CrossRef
  • Socioeconomic Burden of Cancer in Korea from 2011 to 2015
    Young Ae Kim, Ye-Rin Lee, Jeongjoo Park, In-Hwan Oh, Hoseob Kim, Seok-Jun Yoon, Keeho Park
    Cancer Research and Treatment.2020; 52(3): 896.     CrossRef
  • Structural and Molecular Docking Analytical Studies of the Predicted Ligand Binding Sites of Cadherin-1 in Cancer Prognostics


    Olalekan Olanrewaju Bakare, Adewale Oluwaseun Fadaka, Marshall Keyster, Ashley Pretorius
    Advances and Applications in Bioinformatics and Chemistry.2020; Volume 13: 1.     CrossRef
  • Influencing Factors of Transportation Costs regarding Healthcare Service Utilization in Korea
    Su Yeon Jang, Jeong Yeon Seon, In-Hwan Oh
    Journal of Korean Medical Science.2020;[Epub]     CrossRef
  • Measuring the Economic Burden of Disease and Injury in Korea, 2015
    Ye-Rin Lee, Bogeum Cho, Min-Woo Jo, Minsu Ock, Donghoon Lee, Doungkyu Lee, Moon Jung Kim, In-Hwan Oh
    Journal of Korean Medical Science.2019;[Epub]     CrossRef
  • Complementary medicine use and costs in patients with breast cancer who experienced treatment-related side effects: A cross-sectional survey in Korea
    Sola Han, Bo-Hyoung Jang, Hae Sun Suh, Deok-Sang Hwang
    Complementary Therapies in Medicine.2019; 44: 210.     CrossRef
  • Financial barriers related to breast cancer screening and treatment: A cross-sectional survey of women in Kenya
    Sujha Subramanian, Robai Gakunga, Madeleine Jones, Asaph Kinyanjui, Emily Ochieng’, Nancy Gikaara, Maluni, David Wata, Anne Korir, Zipporah Ali
    Journal of Cancer Policy.2019; 22: 100206.     CrossRef
  • The economic burden of rotavirus infection in South Korea from 2009 to 2012
    Kyung Suk Lee, Ye-Rin Lee, So-Youn Park, In-Hwan Oh, Donald R. Olson
    PLOS ONE.2018; 13(3): e0194120.     CrossRef
  • Household Costs of Breast Cancer Morbidity: An Empirical Assessment from Pakistan
    Hafiz Zahid Mahmood, Imran Hameed Khaliq, Zafar Iqbal Bhatti, Kimberly J. Wilson, Khalid Masood Gondal, Summaira Malik, Shakila Zaman
    SSRN Electronic Journal .2018;[Epub]     CrossRef
  • Comparative clinicopathological and cytomorphological analyses of peritoneal carcinomatosis associated with metastatic breast carcinoma and primary peritoneal/ovarian carcinoma in patients with a history of breast carcinoma
    Kiyong Na, Jung-Yun Lee, Ji-Youn Sung, Gun Min Kim, Ja Seung Koo, Hyun-Soo Kim
    Virchows Archiv.2018; 473(2): 165.     CrossRef
  • Breast Cancer Detection Using Infrared Thermal Imaging and a Deep Learning Model
    Sebastien Jean Mambou, Petra Maresova, Ondrej Krejcar, Ali Selamat, Kamil Kuca
    Sensors.2018; 18(9): 2799.     CrossRef
  • The effect of tamoxifen therapy on the endometrium and ovarian cyst formation in patients with breast cancer
    Seul Lee, Yun Hwa Kim, Seung Chul Kim, Jong Kil Joo, Dong Suh Seo, Ki Hyung Kim, Kyu Sup Lee
    Obstetrics & Gynecology Science.2018; 61(5): 615.     CrossRef
  • The human circadian clock from health to economics
    Bala S. C. Koritala, Selim Çakmaklı
    PsyCh Journal.2018; 7(4): 176.     CrossRef
  • Economic Burden for Lung Cancer Survivors in Urban China
    Xin Zhang, Shuai Liu, Yang Liu, Jian Du, Wenqi Fu, Xiaowen Zhao, Weidong Huang, Xianming Zhao, Guoxiang Liu, Zhengzhong Mao, Teh-wei Hu
    International Journal of Environmental Research and Public Health.2017; 14(3): 308.     CrossRef
  • Strategies for Appropriate Patient-centered Care to Decrease the Nationwide Cost of Cancers in Korea
    Jong-Myon Bae
    Journal of Preventive Medicine and Public Health.2017; 50(4): 217.     CrossRef
  • Productivity losses and public finance burden attributable to breast cancer in Poland, 2010–2014
    Błażej Łyszczarz, Ewelina Nojszewska
    BMC Cancer.2017;[Epub]     CrossRef
  • The Economic Burden of Otitis Media in Korea, 2012: A Nationally Representative Cross-Sectional Study
    Young-Eun Kim, Ye-Rin Lee, So-Youn Park, Kyung Suk Lee, In-Hwan Oh
    BioMed Research International.2016; 2016: 1.     CrossRef
  • The Burden of Cancer in Korea during 2012: Findings from a Prevalence-Based Approach
    Young-hoon Gong, Seok-Jun Yoon, Min-Woo Jo, Arim Kim, Young Ae Kim, Jihyun Yoon, Hyeyoung Seo, Dongwoo Kim
    Journal of Korean Medical Science.2016; 31(Suppl 2): S168.     CrossRef
  • 14,065 View
  • 188 Download
  • 26 Web of Science
  • 26 Crossref
Close layer

Cancer Res Treat : Cancer Research and Treatment
Close layer
TOP